We are live on ! Find out more
Tudor Investment Corp

Tudor Investment Corp Portfolio holdings

AUM $53.9B
1-Year Est. Return 29.12%
This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
+29.12%
3 Year Est. Return
+77.1%
5 Year Est. Return
+83.79%
10 Year Est. Return
+526.01%
AUM
$4.72B
AUM Growth
+$811M
Cap. Flow
+$725M
Cap. Flow %
15.35%
Top 10 Hldgs %
50.89%
Holding
2,164
New
473
Increased
444
Reduced
615
Closed
579

Sector Composition

Rank Sector Weight
1 Healthcare 7%
2 Industrials 6.48%
3 Technology 5.65%
4 Financials 4.88%
5 Consumer Discretionary 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRD
1451
DELISTED
MEMORIAL RESOURCE DEV CORP COM STK (DE)
MRD
$162K ﹤0.01%
10,200
-87,391
-90% -$1.24M
TSEM icon
1452
Tower Semiconductor
TSEM
$29.3B
$161K ﹤0.01%
12,959
-1,215
-9% -$14.6K
AEL
1453
DELISTED
American Equity Investment Life Holding Company
AEL
$161K ﹤0.01%
11,317
-20,683
-65% -$312K
RM icon
1454
Regional Management Corp
RM
$291M
$159K ﹤0.01%
+10,858
New +$178K
AGTC
1455
DELISTED
Applied Genetic Technologies Corporation
AGTC
$158K ﹤0.01%
11,161
-1,732
-13% -$27K
ARIA
1456
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$158K ﹤0.01%
21,400
-5,669
-21% -$42.5K
FBRC
1457
DELISTED
FBR & Co. Common Stock
FBRC
$158K ﹤0.01%
10,554
EPIQ
1458
DELISTED
EPIQ SYSTEMS INC
EPIQ
$157K ﹤0.01%
+10,752
New +$158K
CYTK icon
1459
Cytokinetics
CYTK
$10.4B
$156K ﹤0.01%
16,470
+1,462
+10% +$12K
CORT icon
1460
Corcept Therapeutics
CORT
$12.3B
$155K ﹤0.01%
28,449
-350
-1% -$1.82K
NVRI icon
1461
Enviri
NVRI
$618M
$155K ﹤0.01%
23,271
-42,475
-65% -$277K
VIVS
1462
VivoSim Labs
VIVS
$1.29M
$155K ﹤0.01%
174
+50
+40% +$33.5K
ACHN
1463
DELISTED
Achillion Pharmaceuticals
ACHN
$155K ﹤0.01%
19,846
-20,113
-50% -$173K
SRC
1464
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$150K ﹤0.01%
+2,626
New +$137K
TPH
1465
DELISTED
Tri Pointe Homes
TPH
$147K ﹤0.01%
12,400
-52,752
-81% -$618K
BOX icon
1466
Box
BOX
$4.68B
$145K ﹤0.01%
+14,000
New +$167K
MCRN
1467
DELISTED
Milacron Holdings Corp.
MCRN
$145K ﹤0.01%
+10,000
New +$162K
GRPN icon
1468
Groupon
GRPN
$932M
$144K ﹤0.01%
2,217
-19,804
-90% -$1.46M
VRA icon
1469
Vera Bradley
VRA
$97.8M
$144K ﹤0.01%
+10,157
New +$164K
TCRT icon
1470
Alaunos Therapeutics
TCRT
$4.86M
$143K ﹤0.01%
174
+16
+10% +$17.4K
TGTX icon
1471
TG Therapeutics
TGTX
$7.53B
$143K ﹤0.01%
+23,516
New +$191K
GLBL
1472
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
$143K ﹤0.01%
43,909
-29,666
-40% -$81.1K
LXP icon
1473
LXP Industrial Trust
LXP
$3.57B
$142K ﹤0.01%
2,811
+308
+12% +$14.2K
MDXG icon
1474
MiMedx Group
MDXG
$619M
$142K ﹤0.01%
17,800
-17,000
-49% -$132K
VNDA icon
1475
Vanda Pharmaceuticals
VNDA
$297M
$142K ﹤0.01%
+12,719
New +$123K

Similar funds

Tudor Investment Corp's Q2 2016 Portfolio in Review

As of Q2 2016, Tudor Investment Corp held 2,164 positions worth $4.72B, up 21% from $3.91B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Tudor Investment Corp deployed $725M of net new capital in Q2 2016, opening 473 new positions and adding to 444 existing holdings. Its largest new stake was Visa: 526,018 shares worth $39M.

By sector, the portfolio is most concentrated in Healthcare at 7% of assets, up from 6.9% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was CR Bard Inc., an estimated $48.8M trimmed.

  • Tudor Investment Corp's largest Q2 2016 buy was Visa: 526,018 shares worth $39M.
  • Tudor Investment Corp added most to Hologic in Q2 2016, an estimated $43.8M increase.
  • Tudor Investment Corp's biggest Q2 2016 reduction was CR Bard Inc., cutting an estimated $48.8M.
  • Tudor Investment Corp fully exited State Street SPDR S&P 500 ETF Trust in Q2 2016, selling an estimated $42.1M.
  • Tudor Investment Corp's ten largest holdings make up 51% of its $4.72B portfolio in Q2 2016.
  • Tudor Investment Corp opened 473 new positions and closed 579 in Q2 2016.
  • Tudor Investment Corp's portfolio value rose 21% quarter-over-quarter to $4.72B.

Based on Tudor Investment Corp's 13F filing for Q2 2016, filed 15 Aug 2016.